Page last updated: 2024-12-08

bw 58c

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID146797
CHEMBL ID4524847
SCHEMBL ID1151720
SCHEMBL ID1542903
SCHEMBL ID917366
SCHEMBL ID13832378
MeSH IDM0131108

Synonyms (29)

Synonym
bw 58c
trans-2-(4-(1,1-dimethylethyl)cyclohexyl)-3-hydroxy-1,4-naphthalenedione
1,4-naphthalenedione, 2-(4-(1,1-dimethylethyl)cyclohexyl)-3-hydroxy-
2-(4'-t-butylcyclohexyl)-3-hydroxy-1,4-naphthoquinone
2-(4-tert-butylcyclohexyl)-3-hydroxy-1,4-naphthoquinone
58c80
2-(4-(1,1-dimethylethyl)cyclohexyl)-3-hydroxy-1,4-naphthalenedione
1,4-naphthalenedione, 2-(4-(1,1-dimethylethyl)cyclohexyl)-3-hydroxy-, trans-
3-(4-tert-butylcyclohexyl)-4-hydroxynaphthalene-1,2-dione
94015-46-0
bw-a 58c
86790-29-6
bupravaquone
SCHEMBL1151720
cis 2-(4'-t-butylcyclohexyl)-3-hydroxy-1,4-naphthoquinone
NWCVRXADYNRXCT-BETUJISGSA-N
cis-2-hydroxy-3-(4-t-butylcyclohexyl)-1,4-naphthquinone
cis-2-(4-t-butylcyclohexyl)-3-hydroxy-1,4-naphthquinone
NWCVRXADYNRXCT-UHFFFAOYSA-N
SCHEMBL1542903
SCHEMBL917366
SCHEMBL13832378
NWCVRXADYNRXCT-JOCQHMNTSA-N
trans-2-hydroxy-3-(4-t-butylcyclohexyl)-1,4-naphthquinone
CHEMBL4524847
2-(4-t-butylcyclohexyl)-3-hydroxy-1,4-naphthoquinone
DB06740
2-[4-(1,1-dimethylethyl)cyclohexyl]-3-hydroxy-1,4-naphthalenedione
DTXSID80916695

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
"Kidneys from male and female Wistar rats dosed with 1 of 3 chemically unrelated pharmacological agents, a pyrazoline BW540C, a naphthoquinone BW58C and the levoisomer of tetramisole, levamisole or the light hydrocarbon Decalin, were examined by light and electron microscopy."( Induction and exacerbation of hyaline droplet formation in the proximal tubular cells of the kidneys from male rats receiving a variety of pharmacological agents.
Astbury, PJ; Morgan, RJ; Parsons, DN; Port, CJ; Read, NG, 1988
)
0.27
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (50.00)18.7374
1990's3 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 20.12

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index20.12 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.45 (4.65)
Search Engine Demand Index20.59 (26.88)
Search Engine Supply Index4.00 (0.95)

This Compound (20.12)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (16.67%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (83.33%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]